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ABSTRACT
Background
Primigravid (PG) women are at risk for pregnancy-associated malaria (PAM). Multigravid (MG)
women acquire protection against PAM; however, HIV infection impairs this protective
response. Protection against PAM is associated with the production of IgG specific for variant
surface antigens (VSA-PAM) expressed by chondroitin sulfate A (CSA)-adhering parasitized
erythrocytes (PEs). We hypothesized that VSA-PAM-specific IgG confers protection by
promoting opsonic phagocytosis of PAM isolates and that HIV infection impairs this response.
Methods and Findings
We assessed the ability of VSA-PAM-specific IgG to promote opsonic phagocytosis of CSA-
adhering PEs and the impact of HIV infection on this process. Opsonic phagocytosis assays
were performed using the CSA-adherent parasite line CS2 and human and murine
macrophages. CS2 PEs were opsonized with plasma or purified IgG subclasses from HIV-
negative or HIV-infected PG and MG Kenyan women or sympatric men. Levels of IgG subclasses
specific for VSA-PAM were compared in HIV-negative and HIV-infected women by flow
cytometry. Plasma from HIV-negative MG women, but not PG women or men, promoted the
opsonic phagocytosis of CSA-binding PEs (p , 0.001). This function depended on VSA-PAM-
specific plasma IgG1 and IgG3. HIV-infected MG women had significantly lower plasma
opsonizing activity (median phagocytic index 46 [interquartile range (IQR) 18–195] versus 251
[IQR 93–397], p¼0.006) and levels of VSA-PAM-specific IgG1 (mean fluorescence intensity [MFI]
13 [IQR 11–20] versus 30 [IQR 23–41], p , 0.001) and IgG3 (MFI 17 [IQR 14–23] versus 28 [IQR
23–37], p , 0.001) than their HIV-negative MG counterparts.
Conclusions
Opsonic phagocytosis may represent a novel correlate of protection against PAM. HIV
infection may increase the susceptibility of multigravid women to PAM by impairing this
clearance mechanism.
The Editors’ Summary of this article follows the references.
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In malaria-endemic areas, pregnant women are more likely
to acquire malaria and to have higher parasite burdens than
nonpregnant individuals [1]. Pregnancy-associated malaria
(PAM), especially in primigravidae, has profound maternal
and fetal health consequences including maternal anaemia
and delivery of low birth-weight infants [2,3]. The effects of
HIV infection on maternal health are superimposed on those
of malaria in sub-Saharan Africa, where approximately 1
million pregnancies each year are complicated by malaria-
HIV coinfection [4]. HIV infection in pregnancy is associated
with higher rates of clinical malaria, higher parasite densities
(both peripheral and placental), and a higher risk of maternal
anaemia and low birth-weight infants [5]. While HIV infection
affects all gravidities, the HIV-associated risk of malaria is
consistently greater in multigravidae [5].
Sequestration of parasitized erythrocytes (PEs) within the
placenta is thought to be the fundamental pathological
mechanism underlying PAM. The placenta appears to select
for a subpopulation of PEs (PAM PEs) that express novel
variant surface antigens (VSA-PAM) and adhere to chon-
droitin sulfate A (CSA), a glycosaminoglycan found in the
placenta [6,7]. The Plasmodium falciparum erythrocyte mem-
brane protein 1 (PfEMP1) family has been identiﬁed as the
major VSA mediating adhesion to CSA [8,9]. PfEMP1 proteins
are encoded by var genes and are expressed on the PE surface
in a mutually exclusive manner [10]. Recently var2csa was
shown to be the principal var gene transcribed in placental
isolates [11] that encodes CSA-binding PfEMP1 [12,13].
Protection against PAM and its clinical consequences
correlates with the acquisition of VSA-PAM-speciﬁc IgG in a
parity-dependent manner [14–17]. Levels of VSA-PAM-spe-
ciﬁc antibodies are low to nonexistent in primigravid (PG)
women and nonpregnant individuals, and tend to increase in
multigravid (MG) women with increasing gravidity [14,16,17].
The presence of HIV infection has been associated with
reduced levels of VSA-PAM-speciﬁc IgG, suggesting a poten-
tial mechanism by which HIV may impair the acquisition or
maintenance of immunity to PAM in multigravidae [18].
VSA-PAM-speciﬁc IgG is thought to protect against PAM
by blocking the adhesion of PEs to CSA in the placenta
[15,16,19]. However, some studies have failed to demonstrate
an association between adhesion-blocking antibodies and
protection against PAM [18,20,21]. Furthermore, plasma
levels of VSA-PAM-speciﬁc IgG do not always correlate with
the ability of the same plasma to block adhesion of PEs to
CSA [18,20,21]. Taken together, these data suggest that in
addition to adhesion blocking, VSA-PAM-speciﬁc IgG may
mediate protection against PAM through other immunologic
mechanisms.
Recently, the IgG subclass proﬁle of malaria-exposed
pregnant women has been investigated. IgG1 and IgG3 are
the classic cytophilic IgG subclasses, whereas IgG2 and IgG4
are typically unable to promote opsonic phagocytosis
because of their weak afﬁnity for Fcc receptors. The IgG
subclass proﬁle of pregnant women toward VSA-PAM was
found to be dominated by IgG1 and IgG3 subclasses [22–24],
suggesting that opsonic phagocytosis might be an important
determinant in the control of placental parasitaemia. The
purpose of this study was to investigate IgG-mediated
mechanisms of protection against PAM and the impact of
HIV infection on this response. We hypothesized that (1)
VSA-PAM-speciﬁc IgG may contribute to protection against
PAM by promoting the opsonic phagocytosis of CSA-binding
PEs and (2) HIV infection results in the inability to generate
or sustain a cytophilic antibody response to PAM PEs,
rendering the HIV-infected MG woman susceptible to PAM.
We show that CSA-binding PEs are cleared by opsonic
phagocytosis in a sex-speciﬁc and parity-dependent manner.
This effector function was mediated by VSA-PAM-speciﬁc
IgG1 and IgG3, but not IgG2 or IgG4. We further
demonstrate that plasma from HIV-infected MG women
had signiﬁcantly lower opsonizing activity than HIV-negative
MG women, and this was associated with lower levels of VSA-
PAM-speciﬁc IgG1 and IgG3.
Methods
Study Population
Plasma samples were obtained at one month postpartum
from PG and MG (parity 3–5) women, with and without HIV
infection, living in an area of holoendemic malaria trans-
mission in Western Kenya. These women were participants in
a cohort study to assess the impact of placental malaria
infection on mother-to-child transmission of HIV infection
[25]. Plasma samples used in this study were randomly
selected from this cohort. Of the 38 HIV-infected women
studied, 29 (76%) had CD4
þ T cell counts above 400 cells/ll, 8
(21%) had counts between 200–400 cells/ll, and one patient
had a CD4
þ T cell count below 200 cells/ll. Plasma from
malaria-exposed men living in the same region of Western
Kenya or unexposed Canadian donors was used as controls in
each assay. Mean age differed signiﬁcantly between PG and
MG women (mean age in years [standard deviation (SD)] PG
18.6 [1.87] versus MG 25.79 [3.58], p , 0.001, by Fisher exact
test) but did not differ signiﬁcantly between MG women and
men (MG 25.79 [3.58] versus men 26.17 [4.93], p ¼ 0.76, by
Fisher exact test). Malaria exposure (urban versus semi-
urban), past history of malaria and presence of parasitaemia
at time of delivery did not differ signiﬁcantly between PG and
MG women. None of the women included in this study
received intermittent preventive treatment or chemoprophy-
laxis during their pregnancy. This study was approved by the
institutional review boards of the Kenya Medical Research
Institute and the Centers for Disease Control and Prevention,
Atlanta, Georgia, United States. Informed consent was
obtained from all participants.
P. falciparum Culture
The laboratory line CS2 was cultured in vitro as described
[26,27]. Cultures were routinely treated with mycoplasma
removal agent (ICN), and were tested and found negative for
mycoplasma by PCR.
Plasma IgG Fractionation
Total IgG was puriﬁed from other plasma components
using a Hitrap Protein G HP Column (Amersham Biosciences,
http://www5.amershambiosciences.com). Neat plasma (200 ll)
was diluted in 20 mM sodium phosphate buffer (pH 7) and
applied to the column. Nonbound plasma proteins were
washed through the column with 20 mM sodium phosphate
buffer (pH 7) and collected (wash fraction). Bound IgG was
eluted from the column using 0.1 M glycine-HCl (pH 2.7) and
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HCl (pH 9) to preserve the activity of acid-labile IgGs. The
presence of protein in wash and eluate fractions was
conﬁrmed by a Bradford protein assay. Both fractions were
dialyzed against PBS, concentrated to the initial plasma
volume using Ultrafree-CL centrifugal ﬁlter devices (30,000
kDa) (Millipore, http://www.millipore.com), and stored at  20
8C.
Plasma Fractionation of Cytophilic and Noncytophilic IgG
Subclasses
To purify cytophilic IgG subclasses from noncytophilic IgG
subclasses,an afﬁnity matrixwith speciﬁcity forIgG2and IgG4
(IgG2þ4 afﬁnity matrix) was prepared using the AminoLink
Plus Immobilization Kit (Pierce, http://www.piercenet.com)
according to the manufacturer’s instructions. Puriﬁed mouse
monoclonal antibodies (anti-IgG2: HP6014, 4 mg; anti-IgG2:
HP6002, 4 mg; anti-IgG4: HP-6025, 2 mg) (Hybridoma Reagent
Laboratory, http://www.hybridoma-reagent-laboratory.com)
were used for matrix preparation.
Neat plasma (200 ll) diluted in 0.1 M phosphate, 0.15 M
NaCl (pH 7.2) was incubated with the IgG2þ4 afﬁnity matrix
for 1 h at room temperature. IgG1 and IgG3 were washed
through the matrix with 0.1 M phosphate, 0.15 M NaCl (pH
7.2) and collected (wash fraction). IgG2 and IgG4 were eluted
from the matrix using 0.1 M glycine-HCl (pH 2.7) and
collected as above (eluate fraction). Both fractions were
dialyzed against PBS, concentrated to the initial plasma
volume using Amicon Ultra-15 Centrifugal Filter Units
(50,000 kDa) (Millipore), and stored at  20 8C.
Detection of Purified IgG Subclasses by Slot Blot
IgG subclasses were detected in the puriﬁed wash and
eluate fractions using a slot blot. Membranes were probed
with anti-human IgG1 (HP-6001, 1:5,000), anti-human IgG2
(HP-6014, 1:3,000), anti-human IgG3 (HP-6050, 1:3,000), and
anti-human IgG4 (HP-6025, 1:10,000) (Sigma-Aldrich, http://
www.sigmaaldrich.com) for 1 h at room temperature, washed
four times with PBST and incubated with goat anti-mouse
HRP secondary (1:4,000) (Bio-Rad, http://www.bio-rad.com)
for 1 h at room temperature. IgG subclasses were detected by
enhanced chemiluminescence (ECL).
In Vitro Opsonic Phagocytosis Assays
Phagocytosis assays were performed using primary human
monocytes and Cd36
þ/þ or Cd36
 /  murine macrophages as
previously described [26,28]. Macrophages (2.5 3 10
5) were
plated on glass coverslips and cultured for 3 d prior to use. To
opsonize PEs, 50 ll of trophozoite-stage CS2 PEs (5%
haematocrit, parasitaemia 4%–10%) in RPMI-1640 were
incubated with 25 ll of plasma (1:3 dilution) for 30 min at
37 8C. In some cases, plasma was heat-inactivated for 1 h at 56
8C prior to use. Opsonized PEs were washed and added to
macrophages at a ratio of 20 PEs per macrophage and
incubated at 37 8C for 2 h. The coverslips were then washed in
ice-cold water for 30–40 s, ﬁxed, and stained using Diff-
Quick. Phagocytosis was quantiﬁed microscopically, with at
least 500 cells counted per coverslip, and presented as a
phagocytic index, deﬁned as the total number of internalized
PEs per total number of macrophages counted expressed as a
percentage. All assays were performed and interpreted by
staff blinded to the clinical and demographic data. Assays
were performed in duplicate or triplicate and repeated at
least once.
Flow Cytometry
Plasma was ﬁrst preadsorbed with noninfected RBCs for 30
min at room temperature to remove nonspeciﬁc antibodies
directed against RBC antigens. Trophozoite-stage CS2 PEs
(4%–8% parasitaemia) were washed, resuspended in 2%
heat-inactivated fetal bovine serum (FBS)/PBS to a haema-
tocrit of approximately 0.1%, and incubated with pread-
sorbed human plasma (1:10 dilution) in a 96-well plate for 30
min at RT. PEs were then washed three times with 2% FBS/
PBS, and incubated with mouse anti-human IgG1 (1:50)
(HP6069, Zymed, http://www.invitrogen.com), IgG2 (1:20)
(HP6014, Sigma-Aldrich), IgG3 (1:20) (HP6047, Zymed), or
IgG4 (1:50) (HP6025, Sigma-Aldrich) diluted in 2% FBS/PBS
for 30 min at RT. PEs were washed and incubated for 30 min
at RT with Atto-488 goat anti-mouse IgG (1:50) (Sigma-
Aldrich) and ethidium bromide (EtBr) (0.5 lg/well) diluted in
2% FBS/PBS. PEs were ﬁxed in 2% paraformaldehyde, and
analysed on a Becton Dickinson FACSCalibur ﬂow cytometer.
Data were analysed using FlowJo software. 10,000 EtBr-
positive events were collected. For each sample, the Atto-
488 mean ﬂuorescence intensity (MFI) of the EtBr-positive
population was recorded. Plasma from unexposed donors
and pooled plasma from HIV-negative MG Kenyan women
were used as negative and positive controls, respectively, in
each assay. All assays and readings were performed blinded to
clinical and demographic data.
Statistical Analysis
All data were tested for normality using the D’Agostino and
Pearson omnibus normality test. If any of the groups being
compared failed the normality test, nonparametric tests were
used for all comparisons. The Mann-Whitney rank sum test
and the Spearman correlation coefﬁcient were used to assess
statistically signiﬁcance. Statistical analyses were performed
using SigmaStat (http://www.systat.com) and GraphPad Prism
(http://www.graphpad.com).
Results
Opsonizing Activity of Maternal Plasma
VSA-PAM-speciﬁc IgG is thought to protect against PAM by
blocking CSA-adhering PEs in the placenta; however, these
antibodies may also protect by promoting the opsonic
phagocytic clearance of PAM PEs. To test whether opsonic
phagocytosis might be an important determinant in the
control of placental parasitaemia, we compared the ability of
plasma from PG and MG Kenyan women (see Table S1), as well
as sympatric men, to promote the opsonic phagocytic
clearance of trophozoite-stage CS2 PEs. CS2 expresses var2csa
as its dominant var transcript and displays an antigenic and
adhesive phenotype similar to clinical isolates causing placen-
tal malaria [13,18]. Opsonic phagocytosis assays were per-
formed in vitro using primary human monocytes as well as
Cd36
þ/þ and Cd36
 /  murine macrophages. Cd36
 /  macro-
phages were used to eliminate the possibility of scavenger
receptor-mediated uptake [28]. Results obtained were similar
for each macrophage type (see Figure S1), thus only data for
Cd36
 / macrophagesarepresentedhere.AsshowninFigure1,
plasma from unexposed donors, as well as from malaria-
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uptake of CSA-binding PEs. Conversely, plasma from MG
women induced signiﬁcantly higher opsonic phagocytosis of
CS2PEsthanplasma from malaria-exposedPGwomen ormen
(median phagocytic index: MG 49 [interquartile range (IQR)
23–68], PG 9.6 [IQR 6–27], men 14 [IQR 7–19]; MG versus PG, p
¼ 0.0031 [U ¼ 71.0]; MG versus men p ¼ 0.0015 [U ¼ 35.0], by
Mann-Whitney rank sum test). The higher plasma opsonizing
activity of MG donors compared with PG and male donors was
speciﬁc for CS2 PEs and did not appear to be confounded by
age, since plasma from all donors similarly promoted the
opsonic phagocytic uptake of the non-CSA-binding parasite
line ITG (Figure S2). In addition, heat inactivation of comple-
ment in plasma from MG women had no effect on plasma
opsonizing activity (Figure S3). These results demonstrate that
plasma-induced opsonic phagocytosis of CSA-binding PEs is
sex-speciﬁc and parity-dependent, a pattern that parallels the
production of VSA-PAM-speciﬁc IgG.
Role of IgG and IgG Subclasses in Mediating Opsonic
Phagocytosis
To conﬁrm that VSA-PAM-speciﬁc IgG was the plasma
component mediating the opsonic phagocytosis of CS2 PEs,
plasma IgG from MG women was puriﬁed using a Protein G
column. All IgG subclasses bound the column and were
detected in the eluate fraction (Figure 2A), while other
plasma proteins remained in the wash fraction. As expected,
no IgG was detected in the wash fraction (Figure 2A). Opsonic
phagocytosis assays were then performed using the puriﬁed
fractions to opsonize CS2 PEs. As shown in Figure 2B, only
the eluate (IgG-containing) fraction induced opsonic phag-
ocytosis, suggesting that VSA-PAM-speciﬁc IgG, and not some
other plasma component, mediates the opsonic phagocytic
clearance of CS2 PEs.
To assess the relative contribution of the IgG subclasses in
mediating opsonic phagocytosis, we separated the cytophilic
and noncytophilic IgG subclasses from MG plasma. Figure 3A
shows the results of the afﬁnity matrix IgG subclass
puriﬁcation. IgG1 and IgG3 were detected in the wash
fraction, whereas IgG2 and IgG4 were detected in the eluate
Figure 1. Plasma Opsonizing activity of CSA-Binding Parasitized
Erythrocytes Is Sex-Specific and Parity-Dependent
(A) Box (median and IQR) and whisker (range) plot showing phagocytic
index of CSA-binding (CS2) PEs opsonized with plasma from non-
immunes (NI) (n ¼ 3), malaria-exposed males (M) (n ¼ 14), malaria-
exposed PG (n ¼ 21), or malaria-exposed MG (n ¼ 16) donors. Statistical
significance was assessed by Mann-Whitney rank sum test. *M versus MG
p ¼ 0.0015; PG versus MG p ¼ 0.0031.
(B) Photomicrographs show examples of murine macrophage internal-
ization of CSA-binding (CS2) PEs opsonized with plasma from individual
donors.
doi:10.1371/journal.pmed.0040181.g001
Figure 2. VSA-PAM-Specific IgG Mediates Opsonic Phagocytosis of CSA-
Binding Parasitized Erythrocytes
(A) Slot blot detection of IgG subclasses in neat plasma (N) and Protein G
column-purified wash (W) and eluate (E) plasma fractions.
(B) Bar graph showing phagocytic index of plasma opsonized CS2 PEs by
murine macrophages. Results are presented as the mean with SD of
triplicates (n ¼ 3) for three MG patients (P1, P2, and P3).
doi:10.1371/journal.pmed.0040181.g002
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fraction and their uptake by macrophages was measured. As
shown in Figure 3B, only IgG1 and IgG3, but not IgG2 and
IgG4, promoted the opsonic phagocytosis of CS2 PEs.
Influence of HIV on Plasma Opsonizing Activity
HIV infection has been reported to partially impair the
production of VSA-PAM-speciﬁc IgG in pregnancy [18]. This
observation suggests that HIV-infected women might have an
opsonic phagocytic defect compared to their HIV-negative
counterparts, resulting in an impaired ability to clear PAM
PEs. We therefore compared the plasma opsonizing activity
of HIV-negative and HIV-infected pregnant women. Tables
S2 and S3 display the characteristics of the participants whose
plasma samples were used in the following experiments; HIV-
negative and HIV-infected pregnant women did not signiﬁ-
cantly differ on the basis of age, place of residence, placental
malaria prevalence, or placental parasite density. As ex-
pected, plasma from HIV-negative and HIV-infected PG
women had uniformly low plasma opsonizing activity (Figure
4A). Plasma from HIV-negative MG women, however, strongly
induced the opsonic phagocytosis of CS2 PEs, while plasma
from HIV-infected MG women had signiﬁcantly lower plasma
opsonizing activity (median phagocytic index 251 [IQR 93–
397] versus 46 [IQR 18–195], respectively; p ¼ 0.006 [U ¼
143.0], by Mann-Whitney rank sum test) (Figure 4B). Since
IgG1 and IgG3 subclasses mediate the opsonic phagocytic
uptake of CSA-binding PEs, we next tested whether lower
levels of these IgG subclasses could explain the observed
opsonic phagocytic defect in plasma from HIV-infected MG
women. Levels of IgG subclasses speciﬁc for VSA expressed by
CS2 PEs were measured in plasma from HIV-negative and
HIV-infected MG women using ﬂow cytometry. Median
plasma levels of IgG1 and IgG3 with speciﬁcity for CS2 VSA
were signiﬁcantly lower in HIV-infected than in HIV-negative
MG women (IgG1: MFI 13 [IQR 11–20] versus 30 [IQR 23–41],
p , 0.001 (U ¼ 111.0); IgG3: MFI 17 [IQR 14–23] versus 28
[IQR 23–37], p , 0.001 (U ¼ 111.5), by Mann-Whitney rank
sum test) (Figure 5).
Correlation between Plasma Opsonizing Activity and
Levels of VSA-PAM-Specific IgG
Finally, we examined the relationship between plasma
opsonizing activity and levels of VSA-PAM-speciﬁc total
(Figure S4) and cytophilic IgG. There was a strong correlation
between levels of both IgG1 and IgG3 subclasses speciﬁc for
VSA expressed by CS2 PEs and opsonic phagocytosis (r
2 ¼
0.85 and r
2¼0.86, respectively, p , 0.001 (F¼179.7, DFn¼1,
DFd¼44 for IgG1; F¼122.5, DFn¼1, DFd¼44 for IgG3), by
Spearman’s correlation coefﬁcient, with F-test) (Figure 6).
Collectively these data demonstrate that many HIV-infected
women have an opsonic phagocytic defect, which can be
attributed to lower plasma levels of VSA-PAM-speciﬁc
cytophilic antibodies.
Discussion
In this study we demonstrate that CSA-binding PEs are
cleared by opsonic phagocytosis in a sex-speciﬁc and parity-
dependent manner, and that VSA-PAM-speciﬁc IgG1 and
IgG3 mediate this response. In addition, we demonstrate that
plasma from HIV-infected MG women had signiﬁcantly lower
opsonizing activity than HIV-negative MG women, and this
defect was associated with lower levels of VSA-PAM-speciﬁc
IgG1 and IgG3.
Protection against PAM is associated with plasma levels of
VSA-PAM-speciﬁc IgG, which are generally low in PG women
and nonpregnant individuals, and increase with increasing
gravidity [16,17,21,29]. However, the exact mechanisms by
which VSA-PAM-speciﬁc IgG protects against PAM and its
clinical consequences remain incompletely understood. A
number of studies have implicated adhesion blocking as a
major mechanism by which VSA-PAM-speciﬁc IgG prevents
the placental accumulation of CSA-binding PEs and protects
against PAM [15,19,30]. However, other studies have found a
lack of correlation between plasma antiadhesion activity,
Figure 3. VSA-PAM-Specific IgG1 and IgG3 Promote Opsonic Phagocy-
tosis of CSA-Binding Parasitized Erythrocytes
(A) Slot blot detection of IgG subclasses in neat plasma (N) and IgG2þ4
affinity matrix-purified wash (W) and eluate (E) plasma fractions.
(B) Bar graph showing phagocytic index of plasma opsonized CS2 PEs by
murine macrophages. Results are presented as the mean with SD of
triplicates (n ¼ 3) for three MG patients (P4, P5, and P6).
doi:10.1371/journal.pmed.0040181.g003
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protection against PAM, suggesting that other immune
mechanisms may also be involved [18,20,21].
We evaluated the role of opsonic phagocytosis as an
effector mechanism by which VSA-PAM-speciﬁc IgG might
confer protection against PAM. Our results demonstrate that
plasma from MG Kenyan women, but not from PG women or
sympatric men, strongly promoted the opsonic phagocytosis
of CSA-binding PEs (Figure 1). This sex-speciﬁc and parity-
dependent pattern of plasma opsonizing activity parallels the
Figure 4. HIV-Infected Multigravid Women Have Impaired Plasma Opsonizing Activity against CSA-Binding Parasitized Erythrocytes
Box (median and IQR) and whisker (range) plot showing phagocytic index of CS2 PEs opsonized with plasma from (A) NI (n¼6), PG HIV (n¼9), or PG
HIVþ(n¼11) donors, and (B) NI (n¼2), MG HIV (n¼23), or MG HIVþ(n¼23) donors. Statistical significance was assessed by Mann-Whitney rank sum
test. *MG HIV  versus MG HIVþ p ¼ 0.006.
MG HIVþ, HIV-infected MG; MG HIV , HIV-negative MG; NI, nonimmune; PG HIV , HIV-negative PG; PG HIVþ, HIV-infected PG.
doi:10.1371/journal.pmed.0040181.g004
Figure 5. HIV-Infected Multigravid Women Have Lower Levels of VSA-PAM-Specific IgG1 and IgG3
Flow cytometry was used to measure levels of IgG1 (A) and IgG3 (B) with specificity for VSA expressed by CS2 PEs in plasma from NI (n¼3), MG HIV (n
¼23), and MG HIVþdonors (n ¼23). Data shown are MFIs for IgG1 and IgG3 from individual donors gated on EtBr positive cells (PEs). Horizontal bars
indicate the median. Inserts show contour plots of a NI, MG HIV , and MG HIVþ donor, respectively. Statistical significance was assessed by Mann-
Whitney rank sum test. *MG HIV  versus MG HIVþ p , 0.001.
MG HIV , HIV-negative MG; MG HIVþ, HIV-infected MG; NI, nonimmune.
doi:10.1371/journal.pmed.0040181.g005
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against PAM. Opsonic phagocytosis was found to depend on
VSA-PAM-speciﬁc IgG1 and IgG3, since MG plasma depleted
of these subclasses lacked opsonizing activity (Figure 3B).
These data support the hypothesis that VSA-PAM-speciﬁc
IgG promotes the opsonic phagocytic clearance of CSA-
binding PEs and further, that VSA-PAM-speciﬁc IgG1 and
IgG3 mediate this response. Our observations provide a new
putative mechanism by which VSA-PAM-speciﬁc IgG may
protect against PAM. These data suggest that in addition to
adhesion blockade [6,15], opsonic immune mechanisms may
also contribute to protection against PAM. Collectively, these
observations extend the function of VSA-PAM-speciﬁc IgG to
suggest that low levels of antibodies directed against CSA
binding parasites in primigravidae [14,17,21,23,29] may
increase their susceptibility to PAM in at least two ways: (1)
through the inability to block adhesion of PEs to CSA in the
placenta, and (2) through the inability to clear CSA-binding
PEs by opsonic phagocytosis.
Our second aim was to provide a mechanistic explanation
for the increased susceptibility of HIV-infected pregnant
women to PAM. In a previous study, HIV-infected pregnant
Malawian women were found to have lower plasma levels of
total IgG with speciﬁcity for VSA expressed by CS2 PEs [18].
Plasma anti-adhesion activity was not associated with HIV
status, suggesting that HIV infection may impair the
production of other VSA-PAM-speciﬁc antibodies, for exam-
ple opsonizing antibodies [18,21]. A major ﬁnding of our
study is that plasma from HIV-infected MG women demon-
strated signiﬁcantly lower median opsonizing activity toward
CS2 PEs than plasma from HIV-negative MG women (Figure
5B). This observed phagocytic defect could be explained by
lower median levels of VSA-PAM-speciﬁc IgG1 and IgG3 in
plasma from HIV-infected MG women (Figure 6). By contrast,
plasma opsonizing activity of HIV-negative and HIV-infected
PG women was not signiﬁcantly different (Figure 5A). This is
not surprising, since plasma from HIV-negative PG women
already displayed very low opsonizing activity, which could
not be further impaired by HIV infection.
Our ﬁndings that HIV-infected MG women have lower
median plasma levels of VSA-PAM-speciﬁc IgG1 and IgG3,
resulting in lower plasma opsonizing activity toward CSA-
binding PEs, offer a novel mechanism by which HIV infection
may increase the susceptibility of MG women to PAM. Lower
plasma opsonizing activity suggests that HIV-infected MG
women have an impaired ability to clear PAM PEs, which
could help to explain why HIV-infected women experience
more frequent and higher parasite densities than their HIV-
negative counterparts [31]. Furthermore, studies have shown
that the HIV-associated risk of PAM is consistently greater in
multigravidae than in primigravidae [5]. Our data reﬂect this
pattern of HIV-associated susceptibility to PAM since
impairment of opsonizing activity and clearance of CSA-
binding PEs by HIV infection was a unique property of
plasma from MG and not PG women. Importantly, our study
indicates that HIV infection may impair malaria-speciﬁc
humoral immune responses early on during the course of
infection, since many of the HIV-infected women tested had
CD4
þ T cell counts greater than 400 cells/ll.
Our ﬁndings have implications for the rational design and
evaluation of vaccines to protect women against PAM.
Although additional epidemiologic studies are required to
conﬁrm the association, our data implicate levels of VSA-
PAM-speciﬁc IgG1 and IgG3 and opsonic phagocytosis of
CSA-binding PEs as potentially important immune correlates
of protection against PAM. This implication suggests that
candidate PAM vaccines eliciting cytophilic VSA-PAM-spe-
ciﬁc IgG1 and IgG3 subclasses may confer increased
protection against PAM.
Limitations of this study include the use of CS2, a CSA-
binding laboratory isolate, and not placental isolates.
Although CS2 expresses var2csa as do placental isolates, and
although CS2 has an antigenic and adhesive phenotype
similar to fresh placental isolates [13,18], our data require
repetition with placental isolates to conﬁrm the general-
isability of our ﬁndings. Future epidemiological studies will
also be required to conﬁrm whether plasma opsonizing
Figure 6. Correlation between Levels of VSA-PAM-Specific IgG1 and IgG3 and Plasma Opsonizing Activity
Plasma levels of IgG1 and IgG3 subclasses specific for VSA expressed by CS2 PEs measured by flow cytometry were compared with their corresponding
phagocytic index. ‘‘X’’ symbols represent plasma from nonimmune donors (n ¼ 3), open squares represent plasma from multigravid HIV-negative
women (n¼23), and solid triangles represent plasma from multigravid HIV-infected women (n¼23). Levels of IgG1 and IgG3 specific for VSA expressed
by CS2 PEs correlated significantly with plasma opsonizing activity (r
2¼0.85 and r
2¼0.86 respectively, p , 0.001). Statistical significance was assessed
by the Spearman correlation coefficient, with F-test.
doi:10.1371/journal.pmed.0040181.g006
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PAM.
In conclusion, we have identiﬁed the opsonic phagocytosis
of CSA-binding parasites as a potentially important effector
function by which VSA-PAM-speciﬁc cytophilic IgG may
mediate protection against PAM. We have further shown that
HIV-infected MG women have lower median plasma opsoniz-
ing activity toward CSA-binding PEs than their HIV-negative
counterparts, reﬂecting lower plasma levels of cytophilic
VSA-PAM-speciﬁc IgG subclasses. These data provide insight
into the IgG-mediated mechanisms of protection against
PAM and suggest a novel mechanism by which HIV may
impair immunity to malaria in pregnancy.
Supporting Information
Figure S1. Comparison of Phagocytosis of Plasma Opsonized CSA-
Binding PEs between Human Monocytes and CD36
 /  Murine
Macrophages
Phagocytic index of CSA-binding PEs opsonized with plasma from
non-immune (NI), malaria-exposed PG or malaria-exposed MG
women by human monocytes (A) or Cd36
 /  murine macrophages
(B). The higher baseline phagocytosis observed with human mono-
cytes is the result of scavenger receptor (e.g., CD36) mediated uptake.
MG1, HIV-1 infected MG woman; MG2 to MG4, HIV-1 negative MG
women; PG1, HIV-1 negative PG woman; PG2, HIV-1 infected PG
woman. Data are means with SD of triplicates.
Found at doi:10.1371/journal.pmed.0040181.sg001 (40 KB PPT).
Figure S2. Plasma Opsonizing Activity of CD36-Binding Parasitized
Erythrocytes Is Not Sex-Speciﬁc or Parity-Dependent
(A) Box (median and IQR) and whisker (range) plot showing
phagocytic index of CD36-binding (ITG) PEs opsonized with plasma
from malaria-exposed males (M) (n ¼ 12) or malaria-exposed MG
women (n ¼ 10).
(B) Box (median and IQR) and whisker (range) plot showing
phagocytic index of CD36- binding (ITG) PEs opsonized with plasma
from malaria-exposed PG (n ¼ 15) or malaria-exposed MG (n ¼ 5)
donors. All donor plasma samples were assayed in duplicate and both
replicates were included. Statistical signiﬁcance was assessed by
Mann-Whitney rank sum test. None of the comparisons were
signiﬁcant.
Found at doi:10.1371/journal.pmed.0040181.sg002 (12 KB PDF).
Figure S3. Plasma Heat Inactivation Does Not Affect Opsonizing
Activity
Phagocytosis of CSA-binding PEs opsonized with malaria-exposed
MG plasma by Cd36
 /  murine macrophages. Solid bars indicated
non-heat inactivated plasma and hatched bars indicate heat-
inactivated plasma. Data are means with SD of triplicates. Plasma
was heat inactivated for 1 h at 56 8C prior to use.
Found at doi:10.1371/journal.pmed.0040181.sg003 (11 KB PDF).
Figure S4. Correlation between Levels of VSA-PAM-Speciﬁc Total
IgG and Plasma Opsonizing Activity
Plasma levels of total IgG speciﬁc for VSA expressed by CS2 PEs
measured by ﬂow cytometry were compared with their corresponding
phagocytic index. Open squares represent plasma from HIV-negative
MG women (n ¼ 23), and solid triangles represent plasma from HIV-
infected MG women (n ¼ 23). Levels of total IgG speciﬁc for VSA
expressed by CS2 PEs correlated signiﬁcantly with plasma opsonizing
activity (r
2 ¼ 0.787, p , 0.001). Statistical signiﬁcance was assessed by
the Spearman’s correlation coefﬁcient.
Found at doi:10.1371/journal.pmed.0040181.sg004 (10 KB PDF).
Table S1. Characteristics of Participants (Used in Figure 1) According
to Parity
Found at doi:10.1371/journal.pmed.0040181.st001 (12 KB PDF).
Table S2. Characteristics of Primigravid Participants (Used in Figure
4A) According to HIV Status
Found at doi:10.1371/journal.pmed.0040181.st002 (12 KB PDF).
Table S3. Characteristics of Multigravid Participants (Used in Figure
4B) According to HIV Status
Found at doi:10.1371/journal.pmed.0040181.st003 (12 KB PDF).
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Editors’ Summary
Background. Every year, malaria kills more than one million people—
mostly young children. Among adults, pregnant women are most
affected by malaria, a parasitic disease spread by mosquitos. In areas of
Africa where malaria is widespread, about 10,000 women die because of
pregnancy-associated malaria (PAM) each year. In PAM, red blood cells
containing parasites (parasitized erythrocytes or PEs) collect in the
woman’s placenta. These PEs, which stick to a placental molecule called
chondroitin sulfate A (CSA), are covered with parasitic proteins known as
variant surface antigens of PAM (VSA-PAM). Women in their first
pregnancy (primigravid women) are particularly susceptible to PAM,
but multigravid women are more resistant unless they are also infected
with HIV (the virus that causes AIDS), in which case they are extremely
susceptible to PAM. Protection against PAM in multigravid women is
associated with the production of immunoglobulins (proteins made by
the immune system that circulate in the blood and bind to foreign
proteins or antigens) that recognize VSA-PAM. These immunoglobulins
or antibodies are called VSA-PAM-specific IgG and their production
increases with each pregnancy
Why Was This Study Done? It is unclear how VSA-PAM-specific IgG
protects multigravid women against PAM or how HIV infection impairs
this protective response. One possibility is that VSA-PAM-specific IgG
coats the PEs in the placenta to enable immune system cells called
macrophages to recognize and ingest them, a process called opsonic
phagocytosis. In this study, the researchers have investigated whether
opsonic phagocytosis provides multigravid women with protection
against PAM and whether a failure of this form of protective immunity
underlies the susceptibility of HIV-infected multigravid women to PAM.
What Did the Researchers Do and Find? The researchers collected
plasma (the fluid part of blood) from primigravid and multigravid women
(some of whom were infected with HIV) living in a Kenyan region where
malaria is common soon after they gave birth and from men living in the
same area. They then purified IgG1, IgG2, IgG3, and IgG4 from the
plasma samples. These four IgG subclasses have different immune
functions—only IgG1 and IgG3 participate in opsonic phagocytosis. To
measure the ability of the plasma samples and purified IgGs to promote
opsonic phagocytosis, the researchers mixed each sample with a
laboratory isolate of CSA-binding PEs and macrophages and counted
how many PEs the macrophages ingested. Plasma from HIV-negative
multigravid women but not primigravid women or men promoted
opsonic phagocytosis and, in the plasma from multigravid women, this
activity depended on IgG1 and IgG3. HIV-infected multigravid women,
however, had less opsonizing activity in their plasma than HIV-negative
multigravid women and the level of this activity correlated with the
levels of VSA-PAM-specific IgG1 and IgG3 (measured using a technique
called flow cytometry) in the plasma samples of these two groups of
women.
What Do These Findings Mean? These findings support the hypothesis
that VSA-PAM-specific IgG1 and IgG3 promote opsonic clearance of CSA-
binding PEs. Thus, opsonic immune mechanisms may be involved in the
protective response to PAM seen in multigravid women. However,
because all the measurements of opsonic phagocytosis in this study
used a laboratory isolate of PEs, these findings need to be confirmed
using PEs isolated from placentas to check that they are generalizable.
Other findings reported here suggest that HIV-positive multigravid
women are more susceptible to PAM than HIV-negative multigravid
women because reduced amounts of VSA-PAM-specific IgG in their
plasma reduce the ability of opsonic phagocytosis to clear PEs from their
placenta. Overall, these results may have implications for the develop-
ment of vaccines against PAM. For example, they suggest that vaccines
should be designed to stimulate the production of VSA-PAM-specific
antibodies of the IgG1 and IgG3 subclasses. They also suggest that,
provided the link between opsonic phagocytosis and protection against
PAM can be confirmed in population-based studies, new vaccines could
be evaluated for their potential to protect women against PAM by seeing
whether the plasma of vaccinees promotes opsonic phagocytosis of
CSA-binding PEs.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040181.
  US Centers for Disease Control and Prevention information on malaria
and malaria during pregnancy (in English and Spanish)
  World Health Organization information on malaria, including a feature
on malaria in pregnancy (in English, Spanish, French, Arabic, Chinese
and Russian)
  Special Program for Research and Training in Tropical Diseases (TDR)
information on malaria and research into the disease
  Roll Back Malaria Partnership fact sheets on all aspects of malaria,
including malaria in pregnancy (in English, French and Portuguese)
  HIV Insite, information from the University of California at San
Francisco on malaria and HIV
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